Skip to main content

Table 2 Amplicons and p53 alterations according to array CGH clusters and G2I classes of tumors (%)

From: An array CGH based genomic instability index (G2I) is predictive of clinical outcome in breast cancer and reveals a subset of tumors without lymph node involvement but with poor prognosis

 

All

Array CGH clusters

G2I classes

  

a

b

c

d

e

f

1

2

3

Total tumors

135

34

25

16

13

35

12

19

88

28

Tumors with amplicons

64 (47)

14 (41)

8 (32)

10 (63)

7 (54)

17 (49)

8 (67)

3 (16)

41 (47)

20 (71)

Amplicons

296

60

43

37

24

69

63

6

173

117

Amplicons per tumor (mean)

2.2

1.8

1.7

2.3

1.8

2.0

5.3

0.3

2.0

4.2

Amplicons per tumor in tumors with amplicons (mean)

4.6

4.3

5.4

3.7

3.4

4.1

7.9

2

4.2

5.9

5q23.3 (a)

7 (5)

2 ( 6)

3 (12)

0

0

2 ( 6)

0

0

5 (6)

2 (7)

8p12a or 8p12-p11

11 (8)

2 (6)

1 (4)

2 (8)

3 (23)

2 ( 6)

1 (8)

0

8 (9)

3 (11)

11q13.2-q13.3

18 (13)

4 (12)

1 (4)

2 (8)

0

8 (23)

3 (25)

1 (5)

9 (10)

8 (29)

11q14.1a

11 (8)

3 (9)

0

2 (13)

0

5 (14)

1 (8)

1 (5)

7 (8)

3 (11)

12q13.11-q13.12

7 (5)

1 (3)

1 (4)

0

0

3 (9)

2 (17)

0

4 (5)

3 (11)

17q11.2b

6 (4)

1 (3)

1 (4)

0

0

2 (6)

2 (17)

0

3 (3)

3 (11)

17q12e

17 (3)

4 (12)

3 (12)

1 (4)

4 (31)

4 (11)

1 (8)

1 (5)

12 (14)

4 (14)

17q21.1-q21.2

8 (6)

2 (6)

2 (8)

0

2 (15)

2 (6)

0

1 (5)

5 (6)

2 (7)

17q21.31

8 (6)

1 (3)

0

1 (6)

2 (15)

3 (9)

1 (8)

1 (5)

5 (6)

2 (7)

17q21.33

8 (6)

1 (3)

0

1 (6)

2 (15)

2 (6)

2 (7)

0

4 (5)

4 (14)

20q (b)

11 (8)

3 (9)

1 (4)

0

0

3 (9)

4 (33)

0

5 (6)

6 (21)

p53 alteration (c)

39 (29)

11 (32)

5 (17)

5 (31)

4 (31)

7 (20)

7 (58)

0

24 (27)

15 (54)

  1. a) number of tumors (%) with the 11 most recurrent amplicons described in Additional file 2 b) tumors with at least one amplicon on 20q: at 20q11.21 , 20q13.2 or 20q13.31-q32; c) TP53 mutation or immunohistochemistry p53 accumulation.